Glenmede Trust CO Na Cardiovascular Systems Inc Transaction History

Glenmede Trust CO Na

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$34.3 - $44.09 $14,371 - $18,473	-419 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$27.86 - $39.35 $640 - $905	23 Added 5.81%	419 $16,000
Q2 2020 Aug 14, 2020	BUY	$30.3 - $42.55 $2,969 - $4,169	98 Added 32.89%	396 $12,000
Q4 2019 Feb 12, 2020	BUY	$42.29 - $52.2 $4,355 - $5,376	103 Added 52.82%	298 $14,000
Q3 2019 Nov 14, 2019	BUY	$42.06 - $51.64 $3,112 - $3,821	74 Added 61.16%	195 $9,000
Q2 2019 Aug 13, 2019	BUY	$33.93 - $43.66 $4,105 - $5,282	121 New	121 $5,000
Q2 2018 Aug 15, 2018	SELL	$21.73 - $33.15 $4,563 - $6,961	-210 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$23.37 - $29.26 $256,649 - $321,333	-10,982 Reduced 98.12%	210 $4,000
Q3 2017 Nov 14, 2017	BUY	$27.25 - $31.55 $304,982 - $353,107	11,192	11,192 $0

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.